A Phase III, Open-Label, Randomized Study of Atezolizumab in Combination with Bevacizumab Compared with Sorafenib in Patients with Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma

UCI-17-107
NCT03434379
Cancer - Liver
Farshid Dayyani
Open
Treatment
Atezolizumab, Avastin, Bevacizumab, MPDL3280A, Nexavar, Sorafenib
III
Adult
National

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.